Lipocine, Inc. (LPCN)
2.37
-0.02
(-0.84%)
USD |
NASDAQ |
May 08, 16:00
2.37
0.00 (0.00%)
Pre-Market: 20:00
Lipocine EPS Diluted (Quarterly) : -0.5404 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -1.858 |
| Verrica Pharmaceuticals, Inc. | -0.5722 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.672M |
| Revenue (Quarterly) | 0.1194M |
| Total Expenses (Quarterly) | 3.791M |
| Enterprise Value | -5.190M |
| Gross Profit Margin (Quarterly) | 87.60% |
| Profit Margin (Quarterly) | -3.08K% |
| Earnings Yield | -82.57% |
| Normalized Earnings Yield | -82.57 |